Drug Shortage Report for TEVA-NITROFURANTOIN

Last updated on 2024-04-11 History
Report ID 219677
Drug Identification Number 02231016
Brand name TEVA-NITROFURANTOIN
Common or Proper name NITROFURANTOIN 100MG CAPS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) NITROFURANTOIN
Strength(s) 100MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100
ATC code J01XE
ATC description OTHER ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-02-14
Estimated end date 2024-04-30
Actual end date
Shortage status Actual shortage
Updated date 2024-04-11
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2024-04-11 French Compare
v11 2024-04-11 English Compare
v10 2024-03-28 French Compare
v9 2024-03-28 English Compare
v8 2024-03-21 French Compare
v7 2024-03-21 English Compare
v6 2024-03-14 French Compare
v5 2024-03-14 English Compare
v4 2024-02-22 French Compare
v3 2024-02-22 English Compare
v2 2024-02-15 French Compare
v1 2024-02-15 English Compare

Showing 1 to 12 of 12